Clinical Trial Site Selection: Connect Investigator Fit With Operating Capacity

Assess the study pathway, not a profile in isolation

A site profile can summarize experience, specialties, rooms, equipment, and patient access. Those facts become more useful when the team relates them to the proposed protocol. The central question is how the investigator and local team would support this study’s population, procedures, reporting, visits, and follow-up within their existing commitments.

Start with the requirements that are most likely to determine fit. A specialist assessment, a procedure pathway, a narrow treatment history, or a demanding screening sequence may change the review more than a general list of capabilities. Bring the right clinical and operational people into that discussion early.

Ask the investigator to interpret the clinical fit

Investigator expertise is more useful than a therapeutic label alone. Discuss the defining population, clinical assessments, relevant care relationships, and the oversight the study requires. This helps the sponsor understand both the practice’s strengths and the questions that need further review before a commitment.

WGR draws on an established clinical foundation through our sister company WCR in South Florida and Puerto Rico. Our therapeutic-area review connects the indication with the proposed investigators and resources. It does not assume every practice has the same specialty access or can perform the same procedures.

WCR's approach to investigator involvement offers further context for evaluating clinical fit alongside patient access and coordinated operations.

Review capacity across the full schedule

A site may be able to arrange screening and still face pressure later when participants return for longer or more frequent visits. Discuss the study’s pattern of work, including clinical-review time, sample processing, system use, data completion, and monitoring follow-up. These tasks can compete for the same staff and rooms.

Ask the team to describe a representative busy day and how additional study activity would fit. The aim is to understand staffing and resource assumptions, not to demand a perfect prediction. A clear explanation of capacity is more useful than an unsupported statement that the site can take as much work as the study needs.

• Confirm the proposed investigator, oversight responsibilities, and clinical review pathway.
• Review target-patient access against the defining protocol criteria.
• Map procedures and resources to confirmed local or external arrangements.
• Consider repeat visits, documentation, monitoring work, and backup coverage.

Keep the startup plan tied to feasibility

Feasibility findings should carry into activation rather than disappear after selection. A dependency identified during review needs an owner and resolution route. If a procedure requires an external arrangement or a staff member needs training, the startup plan should show that work and its effect on the first visit.

Our feasibility and startup process connects these stages. Central operations can help organize budgets, contracts, regulatory preparation, resources, and systems around the local team. The value is a more coherent pathway from the initial discussion to a prepared study visit.

Choose a relationship that can surface uncertainty

Good site selection depends on useful communication after the questionnaire. A team should be able to explain what it knows, what remains conditional, and what would change its estimate. Sponsors and CROs can support that honesty by clarifying priorities, sharing protocol context, and making decisions accessible when questions arise.

For urgent programs, the same principles apply with greater attention to the remaining timeline. Our trial rescue review asks whether the proposed contribution can address the actual study need. Selection is the beginning of an operating partnership, and its quality depends on the work the teams can do together.

Ask for a study-specific operating summary

Before finalizing the discussion, ask the site to summarize the proposed investigator, relevant patient pathway, required procedures, resource arrangements, and unresolved startup needs. A short summary gives the sponsor a way to see how the different answers fit together. It also creates a useful handoff for the people who will manage activation after selection.

Review whether the summary contains assumptions presented as facts. If a procedure partner, staff arrangement, or system dependency still needs confirmation, show that condition and the route to resolve it. This is a practical way to preserve the value of feasibility work as the relationship moves from an initial assessment into an operating study.